| Epidemiology of lung cancer in China |
58 |
| Efficacy and safety of nivolumab in non-small cell lung cancer with preexisting interstitial lung disease |
26 |
| ALK-rearrangement in non-small-cell lung cancer (NSCLC) |
22 |
| Long non-coding RNA OIP5-AS1 promotes proliferation of lung cancer cells and leads to poor prognosis by targeting miR-378a-3p |
20 |
| Role of long non-coding RNA in drug resistance in non-small cell lung cancer |
18 |
| High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma |
17 |
| Comprehensive analysis of circular RNA profiling in AZD9291-resistant non-small cell lung cancer cell lines |
17 |
| Neutrophil-to-lymphocyte ratio after four weeks of nivolumab administration as a predictive marker in patients with pretreated non-small-cell lung cancer |
16 |
| Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non-small cell lung cancer patients |
15 |
| Risk factors of lymph node metastasis in patients with non-small cell lung cancer <= 2 cm in size: A monocentric population-based analysis |
13 |
| MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25 |
13 |
| Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A hypothesis-generator preliminary report |
13 |
| Clinical significance and biological role of cancer-derived Type I collagen in lung and esophageal cancers |
12 |
| High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non-small cell lung cancer |
12 |
| Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways |
11 |
| Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer |
11 |
| Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling |
11 |
| CircAGFG1 sponges miR-203 to promote EMT and metastasis of non-small-cell lung cancer by upregulating ZNF281 expression |
11 |
| Knockdown of long non-coding RNA linc-ITGB1 inhibits cancer stemness and epithelial-mesenchymal transition by reducing the expression of Snail in non-small cell lung cancer |
10 |
| Apatinib monotherapy for advanced non-small cell lung cancer after the failure of chemotherapy or other targeted therapy |
10 |
| Updates on the pathogenesis of advanced lung cancer-induced cachexia |
10 |
| Updates to the antitumor mechanism of oncolytic virus |
10 |
| Correlation between progression-free survival, tumor burden, and circulating tumor DNA in the initial diagnosis of advanced-stage EGFR-mutated non-small cell lung cancer |
10 |
| hsa_circ_000 a potential prognostic biomarker in lung adenocarcinoma |
10 |
| Feasibility of re-biopsy and EGFR mutation analysis in patients with non-small cell lung cancer |
10 |
| Therapeutic targeting of cellular stress responses in cancer |
9 |
| Tumor suppressive roles of eugenol in human lung cancer cells |
9 |
| Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma |
9 |
| Prognostic role of preoperative platelet, fibrinogen, and D-dimer levels in patients with non-small cell lung cancer: A multicenter prospective study |
9 |
| Overexpression of long non-coding RNA KCNQ1OT1 is related to good prognosis via inhibiting cell proliferation in non-small cell lung cancer |
9 |
| New method of lung cancer detection by saliva test using surface-enhanced Raman spectroscopy |
9 |
| Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study |
8 |
| Low pre-treatment nutritional index is significantly related to poor outcomes in small cell lung cancer |
8 |
| PD-L1 expression in ROS1-rearranged non-small cell lung cancer: A study using simultaneous genotypic screening of EGFR, ALK, and ROS1 |
8 |
| Prevalence of ROS1 fusion in Chinese patients with non-small cell lung cancer |
8 |
| Scutellarin suppresses proliferation and promotes apoptosis in A549 lung adenocarcinoma cells via AKT/mTOR/4EBP1 and STAT3 pathways |
8 |
| miR-194 suppresses high glucose-induced non-small cell lung cancer cell progression by targeting NFAT5 |
8 |
| Clinicopathological characteristics, diagnosis, and prognosis of pregnancy-associated breast cancer |
8 |
| IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway |
8 |
| Radiotherapy is an independent prognostic marker of favorable prognosis in non-small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab |
8 |
| Exopolysaccharides from a Codonopsis pilosula endophyte activate macrophages and inhibit cancer cell proliferation and migration |
8 |
| Diagnostic value of microRNAs derived from exosomes in bronchoalveolar lavage fluid of early-stage lung adenocarcinoma: A pilot study |
8 |
| Dielectric properties for non-invasive detection of normal, benign, and malignant breast tissues using microwave theories |
8 |
| Comparison and discussion of the treatment guidelines for small cell lung cancer |
8 |
| Overexpression of ANLN in lung adenocarcinoma is associated with metastasis |
8 |
| Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody |
7 |
| Safety and clinical outcomes of computed tomography-guided percutaneous microwave ablation in patients aged 80 years and older with early-stage non-small cell lung cancer: A multicenter retrospective study |
7 |
| Correlation between radiomic features based on contrast-enhanced computed tomography images and Ki-67 proliferation index in lung cancer: A preliminary study |
7 |
| MiR-873 inhibition enhances gefitinib resistance in non-small cell lung cancer cells by targeting glioma-associated oncogene homolog 1 |
7 |
| MiR-520b restrains cell growth by targeting HDAC4 in lung cancer |
7 |
